节点文献

去羟肌苷散、司他夫定和奈韦拉平联合治疗艾滋病患者6个月疗效观察

The first 6-months evaluation on the efficacy of combined therapy with didanosine,stavudine and nevirapine in AIDS patients

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 卢洪洲胡越凯薛以乐潘启超何云赵清霞尹春煜蒋为民潘孝彰翁心华康来仪

【Author】 LU H ongzhou,HU Yuekai,XUE Yile,et al.Department of Infectious Diseases,Affiliated Ho spital of Fudan University,Shanghai 200040,China

【机构】 复旦大学附属华山医院传染科上海市疾病预防控制中心河南省郑州市第六人民医院上海市疾病预防控制中心 200040200040

【摘要】 目的 观察去羟肌苷散、司他夫定和奈韦拉平 3药联合治疗艾滋病患者 6个月时的疗效及不良反应。方法 艾滋病患者 8例 ,给予去羟肌苷散、司他夫定和奈韦拉平 3药联合治疗 ,随访 6个月。监测患者治疗前、治疗 1个月、治疗 3个月、治疗 6个月时的血浆病毒载量及CD+ 4 T淋巴细胞计数 ,并评价药物不良反应。结果 经过 6个月治疗患者血浆中HIVRNA含量明显降低 ,CD+ 4 T淋巴细胞数量增加 ,药物不良反应轻微。结论 去羟肌苷散、司他夫定和奈韦拉平 3药联合治疗能有效抑制艾滋病病毒的复制 ,机体免疫功能亦有改善 ,并具有良好的耐受性。

【Abstract】 Objective To observe the efficacy and side ef fe cts of combined therapy with didanosine,stavudine and nevirapine in AIDS patient s.Methods Eight patients with AIDS were treated by combination of didanosine,stavudine and nevirapine.All cases were followed up for 6 months.The plasma HIV-1 RNA level and CD 4 T cell counts of the patients were measured a t the beginning of treatment and the end of the first,third and sixth month.Adve rse events were monitored in all of 8 patients.Results The level of plasma HIV-1 RNA was significantly decrea sed( P <0.001),and CD 4 cell counts were significantly increased( P =0.014) in all patients.The adverse effects of the three kinds of drugs were mild durin g the first 6-months.Conclusions During the first 6-months,8 patients who received combined therapy of didanosine,stavudine and nevirapine were well tolerated,and got rapid immunological and antiviral response.

【基金】 教育部留学归国人才基金资助
  • 【文献出处】 临床内科杂志 ,Journal of Clinical Internal Medicine , 编辑部邮箱 ,2004年04期
  • 【分类号】R512.91
  • 【被引频次】8
  • 【下载频次】132
节点文献中: 

本文链接的文献网络图示:

本文的引文网络